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Little is known concerning the biosynthetic and metabolic capabilities of the syphilis agent, Treponema
pailidum, because of the inability to cultivate continuously the organism in vitro. To circumvent the problem
of cultivation, researchers have used recombinant DNA technology to express treponemal protein antigens in
Escherichia coli. However, with a few notable exceptions, the specific cellular roles of these doned treponemal
proteins have not been determined. In this study, a cosmid library of T. pallidum genomic DNA was constructed
and amplified by repackaging infective lambda bacteriophage particles in vivo. Recombinant clones capable of
complementing a null mutation in the E. coli proC gene encoding 1-pyrroline-5-carboxylate (P5C) reductase
(EC 1.5.1.2) were subsequently identified. The complementing activity was eventually localized to a
2.3-kilobase Bgml-Hindm fragment that hybridized to the same-size fragment of a BgL-HindI digest of T.
pallidum DNA. Two proteins of 41 and 27 kilodaltons (kDa) were encoded by this fragment, as determined by
maxiceil analysis. Although only the 41-kDa protein could be specifically precipitated by experimental syphilitic
rabbit antisera, it was the 27-kDa protein that was responsible for the proC-complementing activity. The
recombinant P5C reductase differed from the native E. coli enzyme by a number of biochemical properties. The
cloning of a T. pallidum gene encoding P5C reductase strongly suggests that this pathogen has the ability to
synthesize proline and possibly other amino acids.
A great deal of time and energy has been devoted to the
study of the spirochete Treponema pallidum since this
organism was first shown to be the etiologic agent of human
syphilis. However, analysis of the metabolic and biosyn-
thetic capabilities of T. pallidum has been limited by the lack
of a practical system for culturing the organism in vitro. For
experimental studies, treponemes are usually cultivated in
rabbit testes, from which they are extracted and purified in
only small quantities. This severely limits the amount of
material available for study; in addition, the data obtained
can be confusing because of the presence of contaminating
host material. Despite these limitations, some information
has been obtained from studies that observed the effects of
various media components on motility and survival or from
analysis of the uptake and products of radiolabeled com-
pounds in metabolically active but nonreplicating organisms
(3, 4, 9, 22, 24, 31). Largely because of the failure to cultivate
continuously organisms in vitro and the limited amount of
other information, T. pallidum is generally considered a
highly fastidious organism with complex growth require-
ments (31).
Recently, researchers have been making extensive use of
recombinant DNA technology to study T. pallidum (re-
viewed in reference 23). Treponemal genes are expressed to
varying degrees from native promoters in Escherichia coli
(34), greatly facilitating this type of approach. The identifi-
cation of various protein antigens from T. pallidum has been
accomplished in several different laboratories by screening
genomic libraries with experimental syphilitic rabbit anti-
sera, syphilitic human antisera, or monoclonal antibodies
directed against specific treponemal proteins. This has made
it possible for T. pallidum proteins to be produced in ample
amounts so that they can be purified and further character-
ized. However, in most cases it has been difficult to assign
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specific cellular functions to cloned gene products, although
Pallesen and Hindersson (25) and Isaacs et al. (13) have
cloned and sequenced major endoflagellar proteins, and
Peterson et al. (27) have reported cloning two fibronectin-
binding proteins.
In this study, complementation of E. coli mutations was
used to identify recombinant clones harboring genes whose
products are involved in basic biochemical pathways of T.
pallidum. Such a strategy was previously used to clone a
tryptophan biosynthetic enzyme from a distantly related
spirochete, Leptospira biflexa (39). In addition, this ap-
proach has been applied to the study of several bacterial
pathogens that have been difficult to study either because
they are obligate intracellular parasites (e.g., Rickettsia
prowazekii [17, 38]) or, like T. pallidum, they have not been
cultivated in vitro for reasons that are not yet obvious (e.g.,
Mycobacterium leprae [14, 15]). A cosmid library of T.
pallidum genomic DNA was constructed and subsequently
amplified by repackaging recombinant cosmids into infective
bacteriophage lambda particles in vivo, as previously de-
scribed by Jacobs et al. (14). Recombinant clones capable of
complementing a particular E. coli mutation can then be
identified by infecting cells of the appropriate strain with this
amplified cosmid library and plating on selective medium.
By using this method, plasmids harboring T. pallidum DNA
that complement a null mutation in the proC gene have been
obtained. This locus encodes the enzyme 1-pyrroline-5-
carboxylic acid (P5C) reductase (EC 1.5.1.2), which cata-
lyzes the terminal step in the biosynthesis of proline (8). This
finding suggests that T. pallidum has the capability of syn-
thesizing proline and possibly other amino acids.
MATERIALS AND METHODS
Bacterial strains and growth conditions. T. pallidum
(Nichols strain) was cultivated, harvested, and purified as
previously described (33). Treponema phagedenis biotype
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TABLE 1. Bacterial strains
Strain Genotype Reference(s)
X2764T HB101 X(c1857 b2 redP3 S7) 6, 14
MC4100 F- araDJ39 A(argF-lac) relAl 32
rpsL150
SE5000 MC4100 recA56 32
RK4101 F- metE argH proC lysA rpsL 16
tonA
AB1133 F- argE proA lacY rpsL his thr E. coli Stock
leu mtl xyl araD galK Culture
Collection
Reiter was cultivated at 37°C in Spirolate broth (BBL
Microbiology Systems, Cockeysville, Md.) supplemented
with 10%o heat-inactivated normal rabbit serum (NRS).
Treponemes were enumerated as previously described (33).
E. coli strains used are described in Table 1. Cells were
grown on Luria broth (LB) (21) or LB plus ampicillin (50
,ug/ml) for selection of transductants or transformants. Re-
cipient cells for transduction experiments were grown as
described by Maniatis et al. (19). Strain RK4101 cells were
grown on M63 medium (21) supplemented with leucine (0.3
mM), arginine (0.6 mM), methionine (0.3 mM), lysine (0.3
mM), and proline (2 mM, when required).
Chemicals and reagents. P5C, NADPH, NADH, dithio-
threitol, amino acids, and other chemicals were obtained
from Sigma Chemical Co., St. Louis, Mo. Restriction en-
zymes and T4 DNA ligase were obtained from Bethesda
Research Laboratories, Inc., Gaithersburg, Md. Calf intes-
tinal alkaline phosphatase was obtained from Boehringer
Mannheim Biochemicals, Indianapolis, Ind. [35S]methionine
(11.7 ,uCi/,l) was obtained from ICN Biomedicals, Inc.,
Irvine, Calif. NRS and experimental syphilitic rabbit antise-
rum (ESRA) were obtained as previously described (33).
Preparation of chromosomal and plasmid DNAs. T. palli-
dum cells (2 x 1010) were gradient purified as previously
described (4). High-molecular-weight chromosomal DNAs
from T. pallidum, T. phagedenis, and E. coli cells were
prepared by the method of Saito and Miura (29). Plasmid
DNA was prepared by the method of Bimboim and Doly (5),
and competent cells were prepared by the method of Hana-
han (10). Plasmid pHC79 (12) was obtained from Boehringer
Mannheim, and plasmid pBS was obtained from Stratagene,
La Jolla, Calif. Deletions were generated in plasmid pFG443
by using the exonuclease III-mung bean nuclease system
from Stratagene. All other DNA manipulations were carried
out as described by Maniatis et al. (19).
Cosmid cloning. T. pallidum DNA was partially digested
with Sau3A, and fragments were ligated into the BamHI site
of pHC79 (molar ratio of 10:1, vector to insert), which had
been dephosphorylated with calf intestinal alkaline phos-
phatase. Ligation reactions were packaged in vitro by using
GIGA-GOLD extracts, as described in the Stratagene tech-
nical manual. Recombinant phage particles were titered by
infecting cells of E. coli X2764T and selecting transductants
on LB plates containing ampicillin (50 ,ug/ml). The library
constructed by using X2764T cells was amplified as described
by Jacobs et al. (14). These recombinant cosmid particles
were used to infect cells of E. coli RK4101 in order to screen
for complementing activity on selective medium. Clones
were plated on minimal medium lacking proline plus ampi-
cillin and incubated for 3 days at 37°C.
Southern blot analysis. Chromosomal and plasmid DNAs
were digested to completion with the appropriate restriction
enzymes, electrophoresed on a 1% agarose gel, and trans-
ferred to GeneScreen Plus (Dupont, NEN Research Prod-
ucts, Boston, Mass.) by the method of Southern (36).
Hybridizations were done by using probe DNA labeled with
digoxigenin-dUTP and detected with the Genius nonradio-
active DNA labeling and detection kit as described in the
Boehringer Mannheim technical manual.
Radiolabeling and sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). Specific labeling of plasmid-
encoded proteins in cells of E. coli SE5000 was done by the
maxicell procedure of Sancar et al. (30) as modified by
Stamm et al. (35). Radioimmunoprecipitations were done by
using NRS and ESRA that had been cross-adsorbed with E.
coli cell lysates as described by Stamm et al. (33). Radiola-
beled cell extracts were analyzed by electrophoresis on
12.5% acrylamide slab gels as described by Laemmli (18).
The gels were stained with Coomassie brilliant blue, de-
stained, placed in Enlightning (Dupont) for 15 min, and
processed for fluorography. Molecular size standards were
phosphorylase b (94 kilodaltons [kDa]), bovine serum albu-
min (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30
kDa), soybean trypsin inhibitor (20 kDa), and lysozyme (14.4
kDa), each of which was obtained from Pharmacia, Inc.,
Piscataway, N.J.
Enzyme assays. PSC reductase activity was measured as
described by Rossi et al. (28) except that the assay was
performed at 34 instead of 25°C. The reaction mixture
contained 50 mM KPO4 (pH 6.5), 1 mM dithiothreitol, 0.1
mM EDTA, 0.5 mM P5C, 0.2 mM NADPH, and appropri-
ately diluted enzyme extract. Protein was measured by the
method of Bradford (7) or by A280.
Liquid chromatography. One liter of cells of E. coli
MC4100, RK4101, or RK4101 harboring plasmid pFG443
was grown in minimal medium to stationary phase at 37°C.
The cultures were harvested by centrifugation at 8,000 x g
for 10 min at 4°C, washed, and suspended in 10 ml of 10 mM
Tris (pH 7.4). The cells were lysed by passage through a
French pressure cell (12,000 lb/in2), and cell debris was
removed by centrifugation at 12,000 x g for 10 min at 4°C.
Cell lysate was centrifuged at 100,000 x g for 2 h at 4°C to
remove the membrane fraction, which contained <5% P5C
reductase activity. Supernatant from this step was applied to
a DEAE-Toyopearl 650M column (1.5 by 8 cm) equilibrated
with 0.1 mM dithiothreitol in 10 mM Tris (pH 7.4). The
column was washed until the A280 was <0.05, and protein
was eluted by using a 0 to 0.05 M NaCl gradient. Fractions
were assayed for protein and P5C reductase activity. The
fractions containing enzyme activity were pooled and con-
centrated in a Centricon 10 concentrator (Amicon Corp.,
Danvers, Mass.). Concentrated enzyme extract from the
previous procedure was applied to a Sephacryl S-300 column
(0.5 by 45 cm) that had been equilibrated with 50 mM Tris
(pH 7.2), 1 mM dithiothreitol, and 150 mM NaCl. Protein
was eluted at a flow rate of 12 ml/h, and 0.75-ml fractions
were collected. Column fractions were assayed for protein
(A280) and P5C reductase activity, and those with activity
were pooled. Molecular size standards for gel filtration were
amylase (200 kDa), bovine serum albumin (66 kDa), and
cytochrome c (14 kDa).
RESULTS
Identification of recombinant clones complementing an E.
coliproC mutation. A chromosomal T. pallidum DNA library
was constructed by using cosmid vector pHC79 (see Mate-
rials and Methods), and recombinant infective particles were
transduced into cells of E. coli X2764T. Recombinant clones
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FIG. 1. Restriction maps of plasmids used. Plasmids pFG320, pFG343, and pFG443 are subclones of the original cosmid pMH2B, which
complements the proC mutation in E. coli RK4101. Plasmid pFG443A, which does not complement the proC mutation, is a deletion mutation
generated by removing the SphI-ClaI fragment of pFG443.
were plated on LB agar containing ampicillin. Rapid plasmid
preparations were done on 20 clones from the library, and
analysis on 0.7% agarose gels showed that all plasmids
contained inserts ranging in size from 35 to 45 kilobases (kb).
Four of the plasmids were labeled and used as probes against
vector, E. coli, T. phagedenis, rabbit, and T. pallidum
chromosomal DNAs by Southern analysis. The results
showed that the recombinant plasmids hybridized only to
vector and T. pallidum DNA (data not shown). When pHC79
was used as a probe, no hybridization was detected to T.
pallidum chromosomal DNA. Titers of the recombinant
phage showed that the library contained about 30,000 clones.
The number of recombinant particles initially obtained
theoretically covered the T. pallidum chromosome many
times. However, the quantity of recombinant particles was
insufficient for the purpose of screening for complementing
clones in various E. coli mutant strains. The use of X2764T
cells to store the recombinant library facilitated its amplifi-
cation by in vivo repackaging of cosmid molecules into
phage lambda particles, using the method described by
Jacobs et al. (14). In vivo repackaged particles were titered
and screened, as was the initial library, for insert size and
ability to hybridize to T. pallidum DNA.
In vivo repackaged particles were used to infect cells of E.
coli RK4101 in order to screen for recombinant molecules
that could complement chromosomal mutations in biosyn-
thetic pathways for arginine, methionine, lysine, and proline
(Table 1). Approximately 3,000 transductants were spread
onto each minimal agar plate containing ampicillin and
missing one of the four required amino acids. After incuba-
tion for 3 to 4 days at 37°C, 17 colonies were obtained on the
plate without proline. No colonies were observed on the
selection plates lacking methionine, lysine, or arginine.
Attempts to obtain spontaneous proC+ revertants of strain
RK4101 were negative (frequency of <2 x 10-9).
Plasmid DNA was isolated from several proC-comple-
menting clones and retransformed into competent cells of
strain RK4101, selecting for ampicillin resistance and subse-
quently scoring for the Pro' phenotype. All of the Ampr
transformants were able to grow in the absence of proline.
One plasmid, designated pMH2B, exhibiting proC-comple-
menting activity was selected for further study. pMH2B
DNA was digested with restriction enzyme HindIII, and
fragments were ligated into the multiple cloning site of
vector pBS. Again using RK4101 cells, Pro' subclones were
isolated on selective medium, and the complementing activ-
ity was found to be encoded on an 11.5-kb HindIII fragment
(designated plasmid pFG200). Subsequently, smaller proC-
complementing subclones were isolated from plasmid
pFG200 (Fig. 1). The smallest plasmid containing a contigu-
ous insert fragment, pFG443, contained a 2.3-kb HindIII-
BglII insert. It should be noted that as the insert size
decreased and the expected copy number increased, the
growth rate of RK4101 cells harboring these constructs in
the absence of proline showed a corresponding increase. In
fact, plasmids pFG343 and pFG443 supported growth rates
on minimal medium minus proline comparable to those of
cells of the parental strain supplemented with proline.
Proline biosynthesis in E. coli involves four reactions that
convert glutamate to proline (38). In the first reaction,
glutamate is converted to L-T-glutamyl phosphate by glu-
tamyl kinase, the gene product of proB. Then L-T-glutamyl
pFG320
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TABLE 2. P5C reductase specific activities
Enzyme Sp act
Strain ~Protein activity (p.mol/minStrain (mg/ml) (,umol/min per mg)
per ml)
MC4100 (proC+) 8.5 2.96 0.349
AB1133 (proC+) 7.1 2.35 0.331
RK4101 (proC)(pBS) 6.3 <0.01 <0.002
RK4101(pMH2) 8.3 1.64 0.197
RK4101(pFG343) 4.7 2.08 0.443
RK4101(pFG443) 4.3 2.43 0.588
RK4101(pFG443A) 7.0 <0.01 <0.002
phosphate is reduced by an NADPH-dependent reaction
catalyzed by L-glutamyl-T-semialdehyde dehydrogenase, the
gene product ofproA. L-Glutamyl-T-semialdehyde spontane-
ously cyclizes to form 1-pyrroline-5-carboxylic acid, which
is further reduced to proline by an NADPH-linked reduction
reaction catalyzed by P5C reductase (EC 1.5.1.2), the gene
product of proC (11). In E. coli, the proBA genes comprise
an operon at 5.8 min, whereas proC represents a distinct
transcriptional unit located at 8.9 min on the chromosome
(2). Attempts were made to complement the proA mutation
in E. coli AB1133 (proC+) with Pro' recombinant cosmids,
including pMH2B and its Pro' derivatives. None of the
recombinant Pro' plasmids, when transformed into AB1133
cells, were able to complement the proA mutation. If there
are additional genes in the T. pallidum chromosome encod-
ing proline biosynthetic enzymes, they may also be unlinked
to that encoding the P5C reductase.
Southern blot analysis of pFG443. Plasmid pFG443 DNA
was used as a probe against pBS, pFG443, E. coli (proC+),
T. phagedenis, rabbit, and T. pallidum DNAs. Plasmid
pFG443 was digested with KpnI and HindIII, making use of
the KpnI site in the multiple cloning site of pBS because the
adjacent BgIII site had been lost during subcloning. The size
of the resulting fragment was different from that predicted
for the insert by only 10 base pairs and therefore showed no
apparent change in the migration distance in agarose gels. E.
coli, T. phagedenis, rabbit, and T. pallidum DNAs were
digested with BglII and HindlIl. The 2.3-kb insert in plasmid
pFG443 specifically hybridized to a 2.3-kb fragment of T.
pallidum chromosomal DNA, confirming the origin of the
insert DNA. Plasmid pBS, when used as a probe, hybridized
only to vector DNA. In addition, Southern analysis showed
that every subsequent subclone of pFG200 also contained a
2.3-kb HindIII-BglII fragment that hybridized with the 2.3-
kb insert of pFG443 (data not shown).
P5C reductase activity. P5C reductase activity was easily
detectable in lysates of cells harboring plasmid pMH2B or
any of its derivatives retaining the 2.3-kb Bglll-HindIII
insert responsible for the proC-complementing activity. The
enzyme activity was dependent on the presence of P5C and
NADPH in the assay mixture. In cell lysates, there were
detectable levels of nonspecific oxidation of NADPH to
NADP. Therefore, any background activity that was de-
tected before the addition of P5C to the reaction mixture was
first subtracted in order to determine the final enzyme
activity. Specific activities for PSC reductase were measured
in various cell lysates (Table 2). The levels of enzyme
activity present in RK4101 cells harboring plasmids pMH2B,
pFG343, and pFG443 were increased at least 100- to 300-fold
over levels in cells of the same strain bearing the original
cloning vector (pBS). A deletion mutation of pFG443 was
constructed by removing a SphI-ClaI fragment from the
middle of the 2.3-kb insert of pFG443 (Fig. 1). The resulting
plasmid (pFG443A) was unable to complement the proC
mutation and resulted in a total loss of P5C reductase
activity. In addition, the levels of enzyme activity appeared
to exhibit a gene dosage effect. As the size of insert DNA
was reduced during subcloning into a high-copy-number
vector, levels of enzyme activity tripled. This finding differs
from the reported observation that native P5C reductase
activity in E. coli showed no gene dosage effect. Levels of
enzyme activity could be increased only when the cloned
gene was expressed under the control of an inducible pro-
moter (8).
Comparison of recombinant versus E. coli P5C reductase
activity. When the P5C reductase activity in cell lysates from
the recombinant clones was compared with enzyme activity
from cell lysates of proC+ E. coli cells, several basic
biochemical differences were observed. The two enzymes
exhibited slightly different pH optima (6.9 in proC+ E. coli
cell lysates and 6.5 in E. coli cell lysates from cells harboring
various proC-complementing plasmids). In addition, dif-
ferent saturating levels of NADPH and P5C were measured
for the recombinant enzyme (0.2 and 0.1 mM, respectively)
versus the native E. coli enzyme (0.12 and 0.5 mM, respec-
tively). The P5C reductase activity from E. coli could use
NADH in place of NADPH in the assay system as previ-
ously reported (8, 28). However, the enzyme activity from
cells harboring plasmid pFG443 was barely detectable when
NADH was substituted for NADPH. P5C reductase from
proC+ E. coli cell lysates was inactivated by freezing and
thawing (28), whereas the partially purified enzyme activity
from cell lysates containing recombinant plasmids was stable
to freezing (data not shown).
Proteins from cell extracts of strains MC4100 and
RK4101(pFG443) were separated by anion-exchange chro-
matography as described in Materials and Methods. The
conditions used for the ion-exchange chromatography were
modified from those of Rossi et al. (28) to allow both
recombinant and E. coli enzymatic activities to be retained
on the column under identical conditions. Protein was eluted
from the column with a 0 to 0.4M NaCl gradient, and
fractions were assayed for P5C reductase activity and pro-
tein (A280) (Fig. 2). E. coli P5C reductase activity eluted at an
NaCl concentration of about 0.075 to 0.1 M. In contrast,
recombinant P5C reductase activity eluted as soon as the
NaCl gradient was applied to the column. Fractions contain-
ing enzyme activity were pooled and concentrated in an
Amicon Centricon concentrator. Sephacryl S-300 chroma-
tography was used to estimate the native molecular weight of
the E. coli and recombinant enzymes. Enzyme activity
obtained from the ion-exchange chromatography procedure
was applied to a Sephacryl S-300 column as described in
Materials and Methods. The elution volume of E. coli
enzyme activity suggested a molecular size of 300 ± 20 kDa,
whereas the recombinant treponemal enzyme activity eluted
at a position that suggested a native molecular size of 170 ±
20 kDa (data not shown).
Identification of recombinant proteins in maxicells. Prelim-
inary identification of gene products encoded by plasmids
pFG320, pFG343, pFG443, and pFG443A was attempted by
labeling plasmid-encoded proteins in E. coli maxicells. Two
forms of ,-lactamase migrating at apparent molecular sizes
of 29 and 30 kDa were encoded by the vector, pBS. Maxicell
extracts from cells programmed with either pFG320,
pFG343, or pFG443 showed the production of two additional
prominent protein bands of 27 and 41 kDa. Maxicell analysis
of plasmid pFG443A (a deletion of the SphI-ClaI fragment of
VOL. 172, 1990 2999
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FIG. 2. Elution of P5C reductase activity and protein from a
DEAE-Toyopearl column. (A) Elution profile when cell lysate from
MC4100 (proC+) was applied to the column; (ID) profile when cell
lysate from RK4101 containing pFG443 was eluted from the column.
pFG443 that no longer complemented the proC mutation)
showed that both the 27- and' 41-kDa proteins of pFG443
were replaced by another protein of 37 kDa (data not shown;
see below). Therefore, it was not possible to determine
which of the plasmid-encoded proteins was responsible for
the observed P5C reductase activity solely on the basis of
the analysis of this deletion.
To determine which' protein was most likely responsible
for the proC-complementing activity, a series of unidirec-
tional nested deletions was generated from the multiple
cloning site into the insert DNA of pFG443 (Fig. 3). As much
as 1 kb of insert DNA could be deleted before the comple-


















FIG. 3. Deletion map of plasmids generated from pFG443. Uni-
directional nested deletions obtained by using exonuclease III-mung
bean nuclease were generated in plasmid pFG443 beginning at the
Sacl site in the multiple cloning site of pBS (adjacent to EcoRI)- (see
Materials and Methods). Symbols: ///, region deleted from the
insert DNA; , insert DNA. + or - indicates whether or not the






FIG. 4. Maxicell analysis of representative deletion derivatives
of pFG443. [35S]methionine-labeled maxicell extracts were prepared
and analyzed by SDS-PAGE and autoradiography (see Materials
and Methods). Lanes: 1, vector plasmid pBS; 2, pFG443 (ProC+); 3,
pFG634 (ProC+); 4, pFG573 (ProC-). The positions of unlabeled
molecular size markers are indicated in kilodaltons at the left.
Arrowheads indicate recombinant 41- and 27-kDa proteins.
regions of insert DNA between the SphI and Hindlll sites
resulted in a total loss of activity. Thus, it appeared that the
gene which was responsible for the complementing activity
could be localized to the SphI-HindHI fragment of pFG443.
Gene products of plasmids pFG573 (Pro-) and pFG634
(Pro') were analyzed in maxicells (Fig. 4). Maxicell extracts
of cells programmed with pFG634 (Pro') revealed the pro-
duction of the 27-kDa protein and the loss of the 41-kDa
protein. Maxicell analysis of plasmid pFG573 (Pro-) re-
vealed that neither the 27- nor the 41-kDa protein was
produced. From this analysis, it appeared that the protein
responsible for the proC-complementing activity was the
27-kDa protein. In addition, radioimmunoprecipitations
were done on radiolabeled proteins being expressed in the
maxicell extracts (Fig. 5). High-titer, cross-adsorbed ESRA
did not precipitate any protein from vector-encoded extracts
and did not react with the 27-kDa protein. However, the
41-kDa protein from pFG443 extracts was efficiently precip-
itated by cross-adsorbed ESRA. Additional analysis of pro-
tein from cell extracts of E. coli RK4101 harboring pFG443
by immunoblotting also revealed that cross-absorbed ESRA
detected only a 41-kDa protein and did not react with the
27-kDa protein (data not shown). Cross-adsorbed NRS did
not react with either protein.
DISCUSSION
Recombinant clones harboring T. pallidum genomic DNA
have been obtained that have the ability to complement the
proC mutation of E. coli RK4101. This compnlementing
activity was localized to a 2.3-kb fragment represented by
recombinant plasmid pFG443. The analysis of the gene
products in maxicells programmed with pFG443 revealed the
expression of two prominent proteins that were clearly not
of vector origin. The insert DNA in plasmid pFG443 was
demonstrated to be of T. pallidum origin by two different
criteria. First, the, 2.3-kb BglII-HindIII insert was used as a
probe against genomic DNA from E. coli (proC+), T. phage-
denis biotype Reiter, rabbit, and T. pallidum cells. The insert
hybridized only to a fragment of T. pallidum DNA of
identical size under high-stringency conditions. Second, the
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FIG. 5. Radioimmunoprecipitation of [35S]methionine-labeled
proteins from maxicell extracts. Maxicell extracts were prepared,
and radioimmunoprecipitation with NRS or ERSA was performed
as described in Materials and Methods. Lanes: 1 to 3, pBS extract;
4 to 6, pFG443 extract; 1 and 4, whole extract; 2 and 5, precipitates
obtained with NRS; 3 and 6, precipitates obtained with ESRA. The
positions of unlabeled molecular size markers are indicated in
kilodaltons at the left. Arrowheads indicate the recombinant 27- and
41-kDa proteins.
with ESRA by radioimmunoprecipitation of maxicell ex-
tracts.
Despite the fact that it was not recognized by ESRA, the
27-kDa protein was responsible for the proC-complementing
activity. Unidirectional nested deletions generated from
plasmid pFG443 demonstrated that the complementing ac-
tivity was localized to a SphI-HindIII fragment. Analysis of
the products of various constructs in maxicells verified that
production of the 27-kDa protein strongly correlated with the
ability of plasmids to complement the E. coli proC mutation.
Any construct that lost the complementing activity showed a
corresponding loss of production of the 27-kDa protein in
maxicells. Although constructs that produced only the 41-
kDa protein were not obtained, complementing activity was
clearly retained by plasmids that had lost the ability to
synthesize this protein.
It was somewhat surprising that the 27-kDa protein did not
react with ESRA, since such sera includes antibodies against
most treponemal proteins discerned by SDS-PAGE analysis
(23, 33). Nothing is known concerning the expression of the
27-kDa protein in T. pallidum cells, but this may indicate
either that this protein is not very immunogenic or that it is
synthesized during infection at a level too low to provoke a
host immune response. Attempts to detect P5C reductase
activity in extracts of freshly harvested treponemes were
unsuccessful (data not shown). These studies were frus-
trated by the relatively low amount of available cellular
material and a high background level of nonspecific oxida-
tion of NADPH to NADP.
The recombinant T. pallidum enzyme expressed in E. coli
was clearly different from native E. coli P5C reductase by
several criteria, including pH optimum, Km for substrate,
stability, isoelectric point, and native molecular size. How-
ever, the subunit molecular sizes of the two enzymes are
very similar (26.5 kDa reported for the E. coli enzyme [6]
versus 27 kDa for the recombinant enzyme). The latter
cannot be considered surprising, since yeast P5C reductase
has a similar subunit molecular size (M. Brandriss, personal
communication).
The finding that a gene encoding an enzyme in the proline
biosynthetic pathway has been identified in a T. pallidum
genomic library strongly suggests that this organism has the
capability of synthesizing its own proline. In this regard,
several cosmids have been recently identified that can com-
plement an E. coli proA mutation (F. C. Gherardini, unpub-
lished data). Interestingly, proline and certain other amino
acids are not present in whole human blood (1). Since proline
is not an essential amino acid that must be provided in the
diet, it may not always be available to T. pallidum during
infection of its human host. It is tempting to speculate that
optimum survival of treponemes during infection requires
that these organisms synthesize proline and perhaps other
amino acids as well.
Whereas proC-complementing plasmids were easily iden-
tified in this study, recombinant plasmids that could comple-
ment mutations in three additional amino acid biosynthetic
pathways were not obtained. It remains to be determined
whether this result indicates that T. pallidum lacks the
corresponding genes or whether such genes were not ex-
pressed sufficiently in E. coli to promote growth. Regardless,
the finding of a T. pallidum gene encoding P5C reductase
indicates that this organism may not be nearly as fastidious
in its growth requirements as is currently believed. The
relatively large genome size reported for T. pallidum (20)
certainly suggests that it could possess significant biosyn-
thetic capabilities. It is anticipated that additional new
information concerning such capabilities will emerge by
functional screening of recombinant libraries.
ACKNOWLEDGMENTS
We thank Cindy Peterson and Rebecca Glasser for excellent
technical assistance and Roy Curtiss III for providing bacterial
strains.
This research was supported by Public Health Service grants
A115036 and A119267 (P.J.B.) and A124976 (L.V.S.) from the
National Institute of Allergy and Infectious Diseases. F.C.G. was
supported by National Research Service award A107953 from the
National Institute of Allergy and Diseases.
LITERATURE CITED
1. Altman, P. L., and D. S. Dittmer (eds.). 1974. Biology data book,
2nd ed., vol. 3, p. 1805-1808. Federation of American Societies
for Experimental Biology, Bethesda, Md.
2. Bachmann, B. J., K. B. Low, and A. L. Taylor. 1976. Recali-
brated linkage map of Escherichia coli K-12. Bacteriol. Rev.
40:116-167.
3. Baseman, J. B., and N. S. Hayes. 1974. Protein synthesis by
Treponema pallidum extracted from infected rabbit tissue.
Infect. Immun. 10:1350-1355.
4. Baseman, J. B., J. C. Nichols, and S. Mogerly. 1979. Capacity of
virulent Treponema pallidum (Nichols) for deoxyribonucleic
acid synthesis. Infect. Immun. 23:392-397.
5. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction
procedure for screening recombinant plasmid DNA. Nucleic
Acids Res. 7:1513-1523.
6. Boyer, H. and D. Roulland-Dussoin. 1969. A complementation
analysis of the restriction and modification of DNA in Esche-
richia coli. J. Mol. Biol. 41:459-472.
7. Bradford, M. M. 1976. A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal. Biochem. 72:248-254.
8. Deutch, A. H., C. J. Smith, K. E. Rushlow, and P. J. Kretsch-
mer. 1982. Escherichia coli Al-pyrroline-5-carboxylate reduc-
tase: gene sequence, protein overproduction and purification.
Nucleic Acids Res. 10:7701-7714.
9. Fieldsteel, A. H., J. G. Stout, and F. A. Becker. 1981. Role of
3001VOL. 172, 1990
3002 GHERARDINI ET AL.
serum in survival of Treponema pallidum in tissue culture. In
Vitro. 17:28-32.
10. Hanahan, D. 1983. Studies on transformation of Escherichia coli
with plasmids. J. Mol. Biol. 166:557-580.
11. Hayzer, D. J., and T. Leisinger. 1980. The gene-enzyme rela-
tionships of proline biosynthesis in Escherichia coli. J. Gen.
Microbiol. 118:287-293.
12. Hohn, B., and J. Collins. 1980. A small cosmid for efficient
cloning of large DNA fragments. Gene 11:291-298.
13. Isaacs, R. D., J. H. Hanke, L.-M. Guzman-Verduzco, G. New-
port, N. Agabian, S. A. Lukehart, M. V. Norgard, and J. D.
Radoif. 1989. Molecular cloning and DNA sequence analysis of
the 37-kilodalton endoflagellar sheath protein of Treponema
pallidum. Infect. Immun. 57:3403-3411.
14. Jacobs, W. R., J. F. Barrett, J. E. Clark-Curtiss, and R. Curtiss
HI. 1986. In vivo repackaging-of recombinant cosmid molecules
for analyses of Salmonella typhimurium, Streptococcus mu-
tans, and mycobacterial genomic libraries. Infect. Immun. 52:
101-109.
15. Jacobs, W. R., M. A. Docherty, R. Curtiss III, and J. E.
Clark-Curtiss. 1986. Expression ofMycobacterium leprae genes
from a Streptococcus mutans promoter in Escherichia coli
K-12. Proc. Natl. Acad. Sci. USA 83:1926-1930.
16. Kadner, R. J., and M. J. Liggins. 1973. Transport of vitamin B12
in Escherichia coli: genetic studies. J. Bacteriol. 115:514-521.
17. Kraiuse, D. C., H. H. Winkler, and D. 0. Wood. 1985. Cosmid
cloning of Rickettsia prowazekii antigens in Escherichia coli
I-12. Infect. Immun. 47:157-165.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature (London)
227:680-685.
19. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular
cloning: a laboratory manual. Cold Spring Harbor Laboratory,
Cold Spring Harbor, N.Y.
20. Miao, R., and A. H. Fieldsteel. 1978. Genetics of Treponema
pallidum: relationship between Treponema pallidum and five
cultivable treponemes. J. Bacteriol. 133:101-107.
21. Miller, J. H. 1972. Experiments in molecular genetics. Cold
Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
22. Nichols, J. C., and J. B. Baseman. 1975. Carbon sources utilized
by virulent Treponema pallidum. Infect. Immun. 12:1044 1050.
23. Norris, S. J., J. F. Aldrete, N. H. Axelsen, M. J. Bailey, S. A.
Baker-Zinder, J. B. Baseman, P. J. Bassford, R. E. Baughn, A.
Cockayne, P. A. Hanif, P. Hindersson, S. A. Larsen, M. A.
Lovett, S. A. Lukehart, J. N. Miller, M. A. Moskophidis, F.
Miller, M. V. Norgard, C. W. Penn, L. V. Stamm, J. D. van
Embden, and K. Wicher. 1987. Identity of Treponema pallidum
subsp. pallidum polypeptides: correlation of sodium dodecyl
sulfate-polyacrylamide gel electrophoresis results from different
laboratories. Electrophoresis 8:77-92.
24. Norris, S. J., and D. G. Edmondson. 1986. Serum requirement
for the multiplication of Treponema pallidum in a tissue-culture
system: association of growth-promoting activity with the pro-
tein fraction. Sex. Trans. Dis. 13:207-213.
25. Pallesen, L., and P. Hindersson. 1989. Cloning and sequencing of
a Treponema pallidum gene encoding a 31.3-kilodalton end-
oflagellar subunit (FlaB2). Infect. Immun. 57:2166-2172.
26. Peterson, K. M., J. B. Baseman, and J. F. AMderete. 1983.
Treponema pallidum receptor binding proteins interact with
fibronectin. J. Exp. Med. 157:1958-1970.
27. Peterson, K., J. B. Baseman, and J. F. Alderete. 1987. Molecular
cloning of Treponema pallidum outer envelope fibronectin bind-
ing proteins, P1 and P2. Genitourin. Med. 63:355-360.
28. Rossi, J. J., J. Vender, C. M. Berg, and W. H. Coleman. 1977.
Partial purification and some properties of pyrroline-5-carbox-
ylate reductase from Escherichia coli. J. Bacteriol. 129:108-114.
29. Saito, H., and K.-I. Miura. 1%3. Preparation of transforming
deoxyribonucleic acid by phenol treatment. Biochim. Biophys.
Acta 72:619-629.
30. Sancar, A., A. M. Hack, and W. D. Rupp. 1979. Simple method
for identification of plasmid-coded proteins. J. Bacteriol. 137:
692-693.
31. Sell, S., and S. J. Norris. 1983. The biology, pathology and
immunology of syphilis. Int. Rev. Exp. Pathol. 24:203-276.
32. Silhavy, T. J., M. L. Berman, and L. W. Enquist. 1984.
Experiments with gene fusions. Cold Spring Harbor Labora-
tory, Cold Spring Harbor, N.Y.
33. Stamm, L. V., and P. J. Bassford, Jr. 1985. Cellular and
extraceliular proteins antigens of Treponema pallidum synthe-
sized during in vitro incubation of freshly extracted organisms.
Infect. Immun. 47:799-807.
34. Stamm, L. V., W. S. Dallas, P. H. Ray, and P. J. Bassford, Jr.
1988. Identification, cloning, and purification of protein antigens
of T. pallidum. Rev. Infect. Dis. 10:S403-S407.
35. Stamm, L. V., T. C. Kerner, Jr., V. A. Bankaitis, and P. J.
Bassford, Jr. 1983. Identification and preliminary characteriza-
tion of Treponema pallidum protein antigens expressed in
Escherichia coli. Infect. Immun. 41:709-721.
36. Southern, E. M. 1975. Detection of specific sequences among
DNA fragments separated by gel electrophoresis. J. Mol. Biol.
98:503-517.
37. Vogel, H. J., and B. D. Davis. 1952. Glutamic-'r-semialdehyde
and A'-pyrroline-5-carboxylic acid, intermediates in the biosyn-
thesis of proline. J. Am. Chem. Soc. 74:109-112.
38. Wood, D. O., L. R. Willlamson, H. H. Winkler, and D. C.
Krause. 1987. Nucleotide sequence of the Rickettsia prowazekii
citrate synthase gene. J. Bacteriol. 169:3564-3572.
39. Yelton, D. B., and N. W. Charon. 1984. Cloning of a gene
required for tryptophan biosynthesis from Leptospira biflexa
serovar patoc into Escherichia coli. Gene 28:147-152.
J. BACTERIOL.
